Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Snowdrifton May 06, 2024 7:39am
77 Views
Post# 36024466

RE:It’s Sunday, week review & look ahead time again

RE:It’s Sunday, week review & look ahead time againGlad to hear you&#39;re on the mend, CF.<br /> <br />
canadafan wrote:

First, I'm very glad we got out of the international trade rules/ laws rabbit hole.
While the details c of international trade AKA our Chineees partner A.N...might be important, in reality very small important.
onc has huge relationships with a Roche, , on- going business with SOLTI ( Spain) , Incyte. 

canadian, USA & Caribesn incorperations. International business law, is extrealy complex.
No doubt various changes may or may not effect ONCs business dealings.
However, long before that becomes an inssue, they need FDA approval to market Pelareorep, fir cancer therapy.
No doubt in my mind what so ever, the likes of Roche, & Pfizer, have teams of lawyers dedicated to internatonal trade.
Moving forward. The FDA request from Onc for a phase 3 meeting, is probably on the top 5 list of business items Onc is dealing with.
It was mentioned thst we are on day 22 or so. The ducumet did indicate an answe within 75 days.
Could be in that light, anytime" within" 75 days.
Only the FDA can answer that. 

regardless of when, that answer will set the details & definition of the MBc long awaited phase 3 trial.
The pancreatic cancer next steps? That avenue is wide open. Other than they expect to finalize trial details first half of this year, meaning within next few weeks.
All we know for sure, there is a Q1 cc scheduled for this Thursday.
All of the past clinical updates have indicated positive outcomes.
Stay tuned.
crazy side note. It was mentioned in Andrew's D. Bio thst he brokered a $85million deal with ONC & A.N.
That is a huge upside potential few understand.
There are a lot if bridges to cross. However, even the start up phase 3, MBc does trigger milestone payments to oncolyitics biotech.
At the time , the deal included an upfront upfront payment. Plus mikstones , simplest being the first 20, 40;patients under trial.
longest & most significant being on- going royalties from a marketable product.
While they are miles away from that. The contract, does have value, should Pela get to phase 3.
again, great week ahead.
I was in hospital last week for 3 days , liver complications.due to Covid.
Today, lots of rest. Recovering & a bit better every day.
Always glad to be Canadian. amazing treatment. Zero costs.
We do pay a lot more taxes in Canada. However a hospital stay does not render me in financial concern.
 


 

 

<br /> <br />
<< Previous
Bullboard Posts
Next >>